TY - JOUR
T1 - Overall and Disease Related Mortality in Parkinson's Disease - A Longitudinal Cohort Study
AU - Hoogland, Jeroen
AU - Post, Bart
AU - De Bie, Rob M.A.
N1 - Funding Information: Author disclosures: Jeroen Hoogland reports no disclosures. Rob de Bie reports grants from ZonMw, grants from Parkinson Vereniging (Netherlands patient organization) and unrestricted research grants from GE Health and Medtronic. Bart Post reports no disclosures. Author contributions: Jeroen Hoogland, study concept and design, execution and interpretation of the statistical analyses, drafting the manuscript. Bart Post, study concept and design, acquisition of data, critical revision of manuscript. Rob M.A. de Bie, study concept and design, acquisition of data, critical revision of manuscript. Publisher Copyright: © 2019 - IOS Press and the authors. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Earlier research showed that Parkinson's disease is related to increased overall mortality, but it remains unclear which patient level factors are predictive of increased mortality in Parkinson's disease. Objective: To jointly evaluate potential risk factors for overall and Parkinson's disease (PD) related mortality, we collected detailed information from a cohort of newly diagnosed PD patients which was consequently followed for over a decade. Methods: A total of 133 consecutive patients with newly diagnosed PD were followed for at least 13 years. Survival analysis of observed mortality was used to evaluate risk factors for overall mortality, whereas survival analysis of mortality as corrected for the general population was used to evaluate risk factors for PD-related mortality. Results: Overall mortality increased with age, male sex, higher levodopa equivalent dose, and presence of mild cognitive impairment. PD-related mortality increased with earlier onset of Parkinson's disease, higher levodopa equivalent dose, and mild cognitive impairment. Conclusions: Our findings provide confirmation and extension of risk factors for overall mortality and generate new insights into PD-related mortality.
AB - Earlier research showed that Parkinson's disease is related to increased overall mortality, but it remains unclear which patient level factors are predictive of increased mortality in Parkinson's disease. Objective: To jointly evaluate potential risk factors for overall and Parkinson's disease (PD) related mortality, we collected detailed information from a cohort of newly diagnosed PD patients which was consequently followed for over a decade. Methods: A total of 133 consecutive patients with newly diagnosed PD were followed for at least 13 years. Survival analysis of observed mortality was used to evaluate risk factors for overall mortality, whereas survival analysis of mortality as corrected for the general population was used to evaluate risk factors for PD-related mortality. Results: Overall mortality increased with age, male sex, higher levodopa equivalent dose, and presence of mild cognitive impairment. PD-related mortality increased with earlier onset of Parkinson's disease, higher levodopa equivalent dose, and mild cognitive impairment. Conclusions: Our findings provide confirmation and extension of risk factors for overall mortality and generate new insights into PD-related mortality.
KW - Parkinson disease
KW - cohort studies
KW - mortality
KW - survival analyses
UR - http://www.scopus.com/inward/record.url?scp=85073182993&partnerID=8YFLogxK
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073182993&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31498129
U2 - https://doi.org/10.3233/JPD-191652
DO - https://doi.org/10.3233/JPD-191652
M3 - Article
C2 - 31498129
SN - 1877-7171
VL - 9
SP - 767
EP - 774
JO - Journal of Parkinson's Disease
JF - Journal of Parkinson's Disease
IS - 4
ER -